DE60203895D1 - Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie - Google Patents

Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie

Info

Publication number
DE60203895D1
DE60203895D1 DE60203895T DE60203895T DE60203895D1 DE 60203895 D1 DE60203895 D1 DE 60203895D1 DE 60203895 T DE60203895 T DE 60203895T DE 60203895 T DE60203895 T DE 60203895T DE 60203895 D1 DE60203895 D1 DE 60203895D1
Authority
DE
Germany
Prior art keywords
glucosamine
acetyl
medicament
manufacture
radiotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60203895T
Other languages
English (en)
Other versions
DE60203895T2 (de
Inventor
Qiwang Xu
Junkang Liu
Zetao Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BEIJING SINO-HONGKONG DAFU SCIENCE and TECHNOLOGY OF
BIO-WAVE INSTITUTE OF SUZHOU HI-TECH NEW DISTRICT
Third Military Medical University TMMU
Original Assignee
Bio Wave Inst Suzhou Hi Tec
Bio Wave Institute of Suzhou Hi Tech New District Corp Ltd
Third Military Medical University TMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Wave Inst Suzhou Hi Tec, Bio Wave Institute of Suzhou Hi Tech New District Corp Ltd, Third Military Medical University TMMU filed Critical Bio Wave Inst Suzhou Hi Tec
Application granted granted Critical
Publication of DE60203895D1 publication Critical patent/DE60203895D1/de
Publication of DE60203895T2 publication Critical patent/DE60203895T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60203895T 2001-02-28 2002-02-28 Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie Expired - Lifetime DE60203895T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN01104882A CN1131036C (zh) 2001-02-28 2001-02-28 N-乙酰-d-氨基葡萄糖在制备抑制放化疗副反应药物中的应用
CN01104882 2001-02-28
PCT/CN2002/000119 WO2002067946A1 (fr) 2001-02-28 2002-02-28 Utilisation de la n-acetyl-d-glucosamine dans la preparation de compositions pharmaceutiques utilisees dans la suppression des effets secondaires causes par la radiotherapie et la chimiotherapie

Publications (2)

Publication Number Publication Date
DE60203895D1 true DE60203895D1 (de) 2005-06-02
DE60203895T2 DE60203895T2 (de) 2005-09-29

Family

ID=4654071

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60203895T Expired - Lifetime DE60203895T2 (de) 2001-02-28 2002-02-28 Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie

Country Status (7)

Country Link
US (1) US7037904B2 (de)
EP (1) EP1374873B8 (de)
CN (1) CN1131036C (de)
AT (1) ATE293983T1 (de)
DE (1) DE60203895T2 (de)
HK (1) HK1061530A1 (de)
WO (1) WO2002067946A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210038C (zh) 2003-03-27 2005-07-13 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备用于治疗毒物和药物中毒致脏器损伤的药物中的应用
JP2007506645A (ja) * 2003-09-17 2007-03-22 中国人民解放▲軍▼第三▲軍▼医大学 抗腫瘍および抗転移のための製剤の製造におけるn−アセチル−d−グルコサミンの使用
CN101155591B (zh) * 2005-08-03 2012-01-18 国立癌中心 可用作tg抑制剂的葡萄糖胺及其衍生物
CN104267185B (zh) * 2014-09-12 2016-05-18 范飞舟 检测肿瘤的试剂盒及其专用识别n-乙酰氨基葡萄糖的物质

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4710493A (en) * 1984-08-14 1987-12-01 Albert Landsberger Therapeutic agent for the use in cancer treatment
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5229374A (en) 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
AU3881493A (en) 1992-03-19 1993-10-21 University Of British Columbia, The Method and composition for suppression of side effects of anti-inflammatory drugs
CN1095366C (zh) * 1996-12-27 2002-12-04 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备治疗肠道疾病药物中的应用
CN1067246C (zh) * 1996-12-27 2001-06-20 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备治疗皮肤癣菌的药物中的应用
CN1067245C (zh) * 1996-12-27 2001-06-20 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备治疗呼吸道疾病的药物中的应用

Also Published As

Publication number Publication date
WO2002067946A1 (fr) 2002-09-06
US20040077596A1 (en) 2004-04-22
HK1061530A1 (en) 2004-09-24
EP1374873B1 (de) 2005-04-27
US7037904B2 (en) 2006-05-02
EP1374873A4 (de) 2004-08-11
CN1131036C (zh) 2003-12-17
DE60203895T2 (de) 2005-09-29
ATE293983T1 (de) 2005-05-15
EP1374873B8 (de) 2005-06-29
CN1372929A (zh) 2002-10-09
EP1374873A1 (de) 2004-01-02

Similar Documents

Publication Publication Date Title
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
AP1913A (en) Substituted benzazoles and use thereof as raf kinase inhibitors
RS20090083A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics
ATE328599T1 (de) Antitumorale mittel
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
DE60135647D1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
DK1392328T3 (da) Medikament til beskyttelse i radioterapi
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
DE60203895D1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
ATE537838T1 (de) Kombinationstherapie mit kloretazin(tm)
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
DE60133491D1 (de) Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung
ES2166778T3 (es) Factor de crecimiento ii de tipo insulina como agente antitumoral.
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: THIRD MILITARY MEDICAL UNIVERSITY CHINESE PEOPLE'S

Owner name: BIO-WAVE INSTITUTE OF SUZHOU HI-TECH NEW DISTRICT

Owner name: BEIJING SINO-HONGKONG DAFU SCIENCE & TECHNOLOGY OF

8364 No opposition during term of opposition